November 07, 2024
Editorial

Comments for: TIME FOR PLAN B

While it is encouraging that the federal Food and Drug Administration says it is moving closer to approving the “morning after” pill for sale without a prescription, the Senate should await final approval for the pill before voting on the new head of the agency. Read More

You may also like